HempMeds, a subsidiary of Medical Marijuana, Inc., announced that its Latin American operations achieved its best revenue month ever in June 2021.
Revenue for HempMeds in Latin America increased by 84%, compared to the previous month and 12% year-over-year.
“This is a very exciting accomplishment and we hope that shareholders and customers alike can view this as a promising sign that our company continues to expand on its international growth and become the world’s first truly global cannabis company,” said HempMeds® CEO Raul Elizalde. “Our Argentinian operations are growing every month and in Mexico, we just signed a distribution agreement with a large retailer to sell our CBD products nationwide. We are very proud that our product RH Oil, the first-ever CBD product to be imported into Mexico, has become the most recommended CBD product by doctors in Mexico.”
The company’s previous revenue record occurred in February 2021.
